CYP1B1 and cardiac hypertrophy: To reiterate, our results may shed light on the role of CYP1B1 and its associated mid-chain HETEs metabolite in the development of cardiac hypertrophy and suggest that CYP1B1 could be used a novel target in the treatment of pressure overload-induced cardiac hypertrophy.